MedTrace Logo

Intestinal Fatty Acid-binding Protein (I-FABP) Levels in Pediatric Celiac Patients

NCT03244254 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2017-10-04

No results posted yet for this study

Summary

A prospective, longitudinal study meant to compare blood levels of I-FABP in pediatric celiac patients during diagnosis to levels under gluten free diet, it's correlation with traditional serology testing and questionnaire regarding patient responsiveness to the gluten free diet, and in comparison to a control group.

Conditions

  • Celiac Disease in Children

Sponsors & Collaborators

  • Schneider Children's Medical Center, Israel

    lead OTHER

Principal Investigators

  • Raanan Shamir, Prof · Director

Eligibility

Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-30
Primary Completion
2019-08-31
Completion
2020-08-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03244254 on ClinicalTrials.gov